Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

Submitted by admin on September 21, 2023 - 11:53am
Source: 
BioSpace
News Tags: 
Alvotech
FDA
biosimilars
AVT02
AbbVie
Humira
Headline: 
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
snippet: 

The FDA on Wednesday accepted Alvotech’s Biologics License Application for AVT02, its high-concentration and interchangeable investigational biosimilar for AbbVie’s Humira (adalimumab).

Do Not Allow Advertisers to Use My Personal information